Bli medlem
Bli medlem

Du är här

2016-01-25

Rhenman & Partners Asset Management AB: Rhenman Healthcare Equity L/S awarded international prize for Long Term Performance - Equity Strategies (5 Years) at Eur

PRESS RELEASE, 25 January 2016

The first Nordic fund to receive this award
The fund returned +245% during the five-year period (+28% annualised)
Since inception in June 2009, the fund has returned a total of +323%

The sector fund Rhenman Healthcare Equity L/S was awarded Long Term
Performance - Equity Strategies (5 Years) at the prestigious
EuroHedge Awards in London. The prize refers to the period 2011-2015
and was awarded by Goldman Sachs.

"We are extremely pleased to receive this award. This is the most
respected international prize in Europe for hedge funds, which
demonstrates our ability to generate substantial long-term value for
our investors. To be the best hedge fund over five years says more
than to win it based on performance for a single year. This is the
first time that a Nordic fund has achieved this", said Carl
Grevelius, Head of Investor Relations and Founding Partner.

"Our success depends largely on the managers' close collaboration with
the medical experts in our Scientific Advisory Board. Equally
important is our focus on the healthcare sector, including
pharmaceuticals, medical technology, biotechnology and service, which
gives us a vast number of investment opportunities to choose from."

Rhenman Healthcare Equity L/S is a global healthcare-focused hedge
fund that is part of SEB Fund Services S.A. Luxembourg's umbrella
fund, with Rhenman & Partners Asset Management AB acting as portfolio
manager.

The Fund has an unprecedented return history since the inception in
June 2009. The main fund class, the IC1 (EUR), has risen 323% in
total, corresponding to an average annual return of +25%. In 2015,
the return was +20%. In accordance with the fund prospectus, the fund
was closed to investments from new investors on 31 December 2015 when
total assets under management reached €500m.

For more information, please contact:
Carl Grevelius, Founding Partner / Head of Investor Relations
Phone: +46 8 459 88 83
E-mail: carl@rhepa.com
www.rhepa.com

About Rhenman & Partners
Rhenman & Partners Asset Management is a Stockholm-based asset manager
focusing on the healthcare sector. The company's AUM amount to over
EUR 530m. Rhenman & Partners was founded in 2008 by a trio with
extensive experience of the asset management sector, as well as an
unrivalled track record in the healthcare sector. Henrik Rhenman has
over 20 years' experience of managing successful healthcare funds.

The Rhenman Healthcare Equity L/S fund is unique in that it is
supported by a Scientific Advisory Board composed of eminent
professors, each with over 30 years in their field. The Group has
access to a wide network of scientists and experts at several
recognized institutions worldwide, including the Karolinska
Institute.

The fund has a long term investment horizon and a diversified
portfolio of around 60-80 core positions. Whilst trading around
positions the fund remains diversified across subsectors, company
size and geographies to lower volatility.

For more information, please visit www.rhepa.com
-----------------------------------------------------------
http://news.cision.com/rhenman---partners-asset-management-ab/r/rhenman-...
http://mb.cision.com/Main/6515/9901355/468331.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.